People living with cancer need new advances. Unleash the possibilities.
Patients with cancer are looking to us to develop solutions and create new paths to cancer breakthroughs.
We focus on the science –
and the people
We focus on both solid tumors and hematological malignancies. We know the need is great, which is why we scrutinize promising molecules from every angle to unlock their full potential with the goal of developing transformative therapies that enable patients with cancer to lead better, longer lives.
Expanded access & compassionate use
What are the treatment options?
Expanded access, which is also sometimes called “compassionate use,” is a potential pathway for a patient with an immediately life-threatening condition or serious disease to gain access to an investigational medical product for treatment outside of a clinical trial setting, when no comparable or satisfactory alternative therapeutic options are available and prior to its commercial availability.
Does SpringWorks have an expanded access / compassionate use program?
In cases when a patient may not qualify for a clinical trial, there may be no trials available, or a patient has exhausted all available treatment options, SpringWorks may be able to provide access to eligible patients through our Expanded Access Program.
Requests for access to a SpringWorks investigational therapy must be made voluntarily by the patient’s treating physician. Requests cannot be made directly by an individual patient or a patient’s parent/legal guardian or caregiver.